A case of thoracic esophageal cancer undergone esophagectomy after induction chemotherapy in a Jehovah's Witness

• Published in: The Journal of Medical Investigation Vol. 62; no. 3.4; pp. 264 - 267
• Main Authors: Inoue, Seiya, Miyoshi, Takanori, Aoyama, Mariko, Hino, Naoki, Yamasaki, Shinichi
• Format: Journal Article
• Language: English
• Published: Japan The University of Tokushima Faculty of Medicine 2015
• Subjects: autologous blood transfusion; Combined Modality Therapy; esophageal carcinoma; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Esophagectomy - methods; Female; Humans; Induction Chemotherapy; Jehovah's Witness; Jehovah's Witnesses; Middle Aged; Tomography, X-Ray Computed
• ISSN: 1343-1420; 1349-6867
• DOI: 10.2152/jmi.62.264

We report the case of a 50-year-old female Jehovah's Witness with advanced esophageal cancer who underwent esophagectomy following induction chemotherapy. She visited our hospital complaining of dysphagia and was diagnosed of advanced esophageal cancer by upper endoscopy. She refused allogeneic transfusion. Induction chemotherapy was performed. Severe anemia occurred as an adverse event. A subtotal esophagectomy was performed after her anemia improved. During the surgery, a large volume of replacement fluid was injected, the blood was diluted, and intraoperative bleeding was relatively reduced. Intraoperative blood salvage was made using Cell Saver. The postoperative course were stable by using autologous blood and albumin infusion. The patient was discharged on postoperative day 27. Jehovah's Witnesses with gastrointestinal malignancies can be treated safely by performing surgical therapy based on blood replacement therapy and autologous blood transfusion. J. Med. Invest. 62: 264-267, August, 2015